Pluristem (PSTI) Announces Partnership with CPC Clinical Research for Study on Peripheral Artery Disease
Go back to Pluristem (PSTI) Announces Partnership with CPC Clinical Research for Study on Peripheral Artery Disease| PLURISTEM THERAPEUTICS, Inc. (NASDAQ: PSTI) | Delayed: 1.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.00 | 52 Week High | $1.85 | |||
| Open | $0.00 | 52 Week Low | $0.71 | |||
| Day High | $1.00 | P/E | N/A | |||
| Day Low | $1.00 | EPS | $-0.41 | |||
| Volume | 12 | |||||
